T. Rowe Price Associates »

Humacyte shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $44k 15k 2.85
2023-09-30 $41k 14k 2.94
2023-06-30 $35k 12k 2.92
2023-03-31 $38k 12k 3.17

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Humacyte

Vanguard Group
Millennium Management
Prescott General Partners
Charles Schwab Investment Management
Two Sigma Investments
Private Advisor
Capstone Investment Advisors
Citadel Advisors
Lion Point Capital
United Asset Strategies
GSA Capital Partners
Marshall Wace
Bank of New York Mellon
Clough Capital Partners
Goldman Sachs Group

View all funds holding Humacyte